[MIKAMINOM ANTIFUNGAL THERAPY IN NEWBORNS AND INFANTS WITH SURGICAL PATHOLOGY]

Insights

Multidrug-resistant fungal infections are increasing in neonatal intensive care units (ICUs). Micafungin offers an alternative antifungal therapy for neonates and infants at risk, especially after abdominal surgery.

Area of Science:

  • Neonatal intensive care
  • Infectious diseases
  • Pharmacology

Background:

  • Prolonged antibiotic use in neonatal intensive care units (ICUs) contributes to the rise of drug-resistant fungal infections.
  • Neonates undergoing abdominal surgery face a high risk of developing fungal infections.

Purpose of the Study:

  • To highlight the challenge of invasive fungal infections in neonates.
  • To introduce micafungin as a viable alternative antifungal agent.

Main Methods:

  • Review of current therapeutic challenges in neonatal fungal infections.
  • Evaluation of micafungin as an alternative to fluconazole in neonates and infants.

Main Results:

  • Micafungin is presented as an effective alternative for treating invasive fungal infections in neonates.
  • Dosage recommendations for micafungin (2-8 mg/kg/day) are provided based on clinical assessment.

Conclusions:

  • Micafungin represents a crucial advancement in managing fungal infections in vulnerable neonatal populations.
  • Judicious use of antifungals like micafungin is essential in neonatal ICUs to combat rising resistance.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
1
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
9
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
6.5K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
681
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368